EDIT Editas Medicine, Inc.
EDIT Editas Medicine, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-14 1 neutral converging
POC $2.68 · VWAP $2.85 · -0.5% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
2 watchlists
EDIT Price Structure
Loading timeframes…
Peers
Every watchlist EDIT belongs to, members best 30-day change first — EDIT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
COVERAGE GAP — this name's print date has passed and tonight's bounded news pass did not include it. No coverage was acquired; nothing is asserted about the result. Refill on the next daily or when the name earns a targeted pull.
full note →Against street estimates
How EDIT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about EDIT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 58 days ago · Jun 21
EDIT research tape
35 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.